Bortezomib (VELCADE) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits. [electronic resource]
Producer: 20061107Description: 813-7 p. digitalISSN:- 0923-7534
- Adult
- Aged
- Bone Neoplasms -- drug therapy
- Boronic Acids -- pharmacology
- Bortezomib
- Breast Neoplasms -- drug therapy
- Disease Progression
- Disease-Free Survival
- Female
- Humans
- Male
- Maximum Tolerated Dose
- Middle Aged
- Pleural Neoplasms -- drug therapy
- Protease Inhibitors -- pharmacology
- Pyrazines -- pharmacology
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
- Soft Tissue Neoplasms -- drug therapy
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.